The German ordinance on biological substances (Biostoffverordnung, BioStoffV), the German act on the prevention and control of infectious diseases (Infektionsschutzgesetz, IfSG), risk assessments, recommendations of the Committee on Biological Agents (ABAS) – there are many aspects to consider when handling SARS-CoV-2 samples. The GBN webinar held on 29 April 2020 with Christiane Hartfeldt, Bettina Meinung (both QM Core Team, GBN) and Dr. Jörg Schibel (Biosafety Officer, University Hospital Tübingen) looked at exactly these aspects. Click here to view the slides shown during the webinar [PDF, in German only].
Webinar recordings
Handling infectious samples (regulations)
– Bettina Meinung (QM Core Team)
Adhering to the recommendations of the Committee on Biological Agents (ABAS)
– Dr. Jörg Schibel (Biosafety Officer, University Hospital Tübingen)
Risk assessment with an example
– Bettina Meinung
Practical implementation and application of the QM Manual
– Christiane Hartfeldt (QM Core Team)
© 2024 All rights reserved.
